161 related articles for article (PubMed ID: 24969665)
1. Zinc phthalocyanine conjugated with the amino-terminal fragment of urokinase for tumor-targeting photodynamic therapy.
Chen Z; Xu P; Chen J; Chen H; Hu P; Chen X; Lin L; Huang Y; Zheng K; Zhou S; Li R; Chen S; Liu J; Xue J; Huang M
Acta Biomater; 2014 Oct; 10(10):4257-68. PubMed ID: 24969665
[TBL] [Abstract][Full Text] [Related]
2. A drug carrier targeting murine uPAR for photodynamic therapy and tumor imaging.
Zhou X; Zheng K; Li R; Chen Z; Yuan C; Hu P; Chen J; Xue J; Huang M
Acta Biomater; 2015 Sep; 23():116-126. PubMed ID: 26004218
[TBL] [Abstract][Full Text] [Related]
3. A novel tumor targeting drug carrier for optical imaging and therapy.
Li R; Zheng K; Hu P; Chen Z; Zhou S; Chen J; Yuan C; Chen S; Zheng W; Ma E; Zhang F; Xue J; Chen X; Huang M
Theranostics; 2014; 4(6):642-59. PubMed ID: 24723985
[TBL] [Abstract][Full Text] [Related]
4. Amino-terminal fragment of urokinase inhibits tumor cell invasion in vitro and in vivo: respective contribution of the urokinase plasminogen activator receptor-dependent or -independent pathway.
Li H; Soria C; Griscelli F; Opolon P; Soria J; Yeh P; Legrand C; Vannier JP; Belin D; Perricaudet M; Lu H
Hum Gene Ther; 2005 Oct; 16(10):1157-67. PubMed ID: 16218777
[TBL] [Abstract][Full Text] [Related]
5. Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator.
Mohanam S; Chandrasekar N; Yanamandra N; Khawar S; Mirza F; Dinh DH; Olivero WC; Rao JS
Oncogene; 2002 Nov; 21(51):7824-30. PubMed ID: 12420219
[TBL] [Abstract][Full Text] [Related]
6. A hybrid protein comprising ATF domain of pro-UK and VAS, an angiogenesis inhibitor, is a potent candidate for targeted cancer therapy.
Sun Q; Xu Q; Dong X; Cao L; Huang X; Hu Q; Hua ZC
Int J Cancer; 2008 Aug; 123(4):942-50. PubMed ID: 18528863
[TBL] [Abstract][Full Text] [Related]
7. A tumor-targeted Ganetespib-zinc phthalocyanine conjugate for synergistic chemo-photodynamic therapy.
Huang L; Wei G; Sun X; Jiang Y; Huang Z; Huang Y; Shen Y; Xu X; Liao Y; Zhao C
Eur J Med Chem; 2018 May; 151():294-303. PubMed ID: 29627724
[TBL] [Abstract][Full Text] [Related]
8. Novel theranostic zinc phthalocyanine-phospholipid complex self-assembled nanoparticles for imaging-guided targeted photodynamic treatment with controllable ROS production and shape-assisted enhanced cellular uptake.
Ma J; Li Y; Liu G; Li A; Chen Y; Zhou X; Chen D; Hou Z; Zhu X
Colloids Surf B Biointerfaces; 2018 Feb; 162():76-89. PubMed ID: 29154189
[TBL] [Abstract][Full Text] [Related]
9. DOT corrected fluorescence molecular tomography using targeted contrast agents for small animal tumor imaging.
Tan Y; Cao Z; Sajja HK; Lipowska M; Wang YA; Yang L; Jiang H
J Xray Sci Technol; 2013; 21(1):43-52. PubMed ID: 23507851
[TBL] [Abstract][Full Text] [Related]
10. cDNA transfection of amino-terminal fragment of urokinase efficiently inhibits cancer cell invasion and metastasis.
Zhu F; Jia S; Xing G; Gao L; Zhang L; He F
DNA Cell Biol; 2001 May; 20(5):297-305. PubMed ID: 11410166
[TBL] [Abstract][Full Text] [Related]
11. Tetra-triethyleneoxysulfonyl substituted zinc phthalocyanine for photodynamic cancer therapy.
Kuzyniak W; Ermilov EA; Atilla D; Gürek AG; Nitzsche B; Derkow K; Hoffmann B; Steinemann G; Ahsen V; Höpfner M
Photodiagnosis Photodyn Ther; 2016 Mar; 13():148-157. PubMed ID: 26162500
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of peptide-conjugated phthalocyanine photosensitizers with highly hydrophilic modifications.
Li F; Liu Q; Liang Z; Wang J; Pang M; Huang W; Wu W; Hong Z
Org Biomol Chem; 2016 Apr; 14(13):3409-22. PubMed ID: 26956169
[TBL] [Abstract][Full Text] [Related]
13. Photodynamic therapy and nuclear imaging activities of zinc phthalocyanine-integrated TiO
Yurt F; Ocakoglu K; Ince M; Colak SG; Er O; Soylu HM; Gunduz C; Biray Avci C; Caliskan Kurt C
Chem Biol Drug Des; 2018 Mar; 91(3):789-796. PubMed ID: 29136341
[TBL] [Abstract][Full Text] [Related]
14. [Experimental study of anti-metastasis effect of urokinase amino-terminal fragment gene on human breast cancer cells].
Zhu F; Xing G; He F
Zhonghua Zhong Liu Za Zhi; 2001 Mar; 23(2):115-7. PubMed ID: 11783013
[TBL] [Abstract][Full Text] [Related]
15. A tumor-targeted activatable phthalocyanine-tetrapeptide-doxorubicin conjugate for synergistic chemo-photodynamic therapy.
Ke MR; Chen SF; Peng XH; Zheng QF; Zheng BY; Yeh CK; Huang JD
Eur J Med Chem; 2017 Feb; 127():200-209. PubMed ID: 28063352
[TBL] [Abstract][Full Text] [Related]
16. Core-interlayer-shell Fe
Liu G; Ma J; Li Y; Li Q; Tan C; Song H; Cai S; Chen D; Hou Z; Chen Q; Zhu X
Int J Pharm; 2017 Apr; 521(1-2):19-32. PubMed ID: 28163230
[TBL] [Abstract][Full Text] [Related]
17. Methylsulfonyl Zn phthalocyanine: A polyvalent and powerful hydrophobic photosensitizer with a wide spectrum of photodynamic applications.
İşci Ü; Beyreis M; Tortik N; Topal SZ; Glueck M; Ahsen V; Dumoulin F; Kiesslich T; Plaetzer K
Photodiagnosis Photodyn Ther; 2016 Mar; 13():40-47. PubMed ID: 26529064
[TBL] [Abstract][Full Text] [Related]
18. Investigation of in vitro PDT activities of zinc phthalocyanine immobilised TiO
Yurt F; Ince M; Colak SG; Ocakoglu K; Er O; Soylu HM; Gunduz C; Avci CB; Kurt CC
Int J Pharm; 2017 May; 524(1-2):467-474. PubMed ID: 28365390
[TBL] [Abstract][Full Text] [Related]
19. In vivo targeted deep-tissue photodynamic therapy based on near-infrared light triggered upconversion nanoconstruct.
Cui S; Yin D; Chen Y; Di Y; Chen H; Ma Y; Achilefu S; Gu Y
ACS Nano; 2013 Jan; 7(1):676-88. PubMed ID: 23252747
[TBL] [Abstract][Full Text] [Related]
20. Hexadecafluorinated zinc phthalocyanine: photodynamic properties against the EMT-6 tumour in mice and pharmacokinetics using 65Zn as a radiotracer.
Boyle RW; Rousseau J; Kudrevich SV; Obochi M; van Lier JE
Br J Cancer; 1996 Jan; 73(1):49-53. PubMed ID: 8554982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
